Generate a tailored SOP for Dr. Tessa Swain. Improve your application with a focused, well-structured draft.
Tessa obtained a PhD from the University of Western Australia, focusing on the development and characterization of novel epigenome editing tools for enhanced transcriptional regulation. She furthered her research as a postdoctoral researcher at the Harry Perkins Institute of Medical Research, optimizing molecular tools to explore complex epigenomic landscapes. Tessa also gained industry experience at PYC Therapeutics, honing her skills in large-scale molecular screening tools aimed at identifying potential RNA binding domains for RNA therapeutics. Currently, she is a Research Fellow at the University of Western Australia’s new Australian Centre for RNA Therapeutics Cancer, where her work involves designing RNA therapies tailored for individualized cancer treatments. Her expertise relates to the UN Sustainable Development Goals, contributing particularly to educational advancements in biotechnology and RNA epigenetics.
University of Western Australia • Perth, Australia
Leading research projects focused on RNA therapies for cancer treatment.
Harry Perkins Institute of Medical Research • Perth, Australia
Optimized molecular tools for exploring complex epigenomic landscapes.
PYC Therapeutics • Perth, Australia
Developed molecular screening tools for RNA therapeutics.
Requirements are standardized across the Graduate School for most Master by Coursework programs at UWA.